Open AccessReal-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation
Author(s) -
Whitney L. Gustafson,
John Saunders,
Sara R. Vazquez,
Aubrey E. Jones,
Daniel M. Witt
Publication year - 2019
Publication title -
pharmacy practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 24
eISSN - 1886-3655
pISSN - 1885-642X
DOI - 10.18549/pharmpract.2019.4.1709
Subject(s) - atrial fibrillation , dosing , oral anticoagulant , medicine , anticoagulant , cardiology , warfarin
Off-label DOAC prescribing for stroke prevention in NVAF at University of Utah Health was consistent or lower than previously published studies. Off-label dosing most often involved under-dosing of rivaroxaban. Future research should investigate the role of provider rationale and insight in optimizing DOAC therapy outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom